Opportunistic infections in patients with haematological malignancies in Nigeria

Haematological malignancies (HM) are common clinical conditions encountered in Nigeria. Patients with haematological cancers are immunocompromised and as such are at risk of invasive fungal infections (IFIs). The objective of this review was to highlight the paucity of data on IFIs in patients with...

Full description

Bibliographic Details
Main Authors: Bassey Ewa Ekeng, Kingsley Akaba, Christian Ide, Rita Oladele
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Clinical and Scientific Research
Subjects:
Online Access:http://www.jcsr.co.in/article.asp?issn=2277-5706;year=2022;volume=11;issue=3;spage=175;epage=180;aulast=Ekeng
_version_ 1811343762679398400
author Bassey Ewa Ekeng
Kingsley Akaba
Christian Ide
Rita Oladele
author_facet Bassey Ewa Ekeng
Kingsley Akaba
Christian Ide
Rita Oladele
author_sort Bassey Ewa Ekeng
collection DOAJ
description Haematological malignancies (HM) are common clinical conditions encountered in Nigeria. Patients with haematological cancers are immunocompromised and as such are at risk of invasive fungal infections (IFIs). The objective of this review was to highlight the paucity of data on IFIs in patients with HM in Nigeria and recommendations on the way forward. A literature search for publications from Nigeria on HM including case reports and reviews from 1961 to 2021 yielded 76 publications of which only 9 (11.8%) reported infections in HM. Eight publications documented infection by viruses while only one publication documented bacterial infection. Viruses (73/93, 78.5%) including human cytomegalovirus (n = 19, 20.4%), Hepatitis B virus (n = 15, 16.1%), hepatitis C virus (n = 6, 6.5%) and human T-lymphotropic virus (n = 2, 2.2%) were the commonest causative agents of infections with HIV (n = 31, 33.3%) as the predominant pathogen. Mycobacterium tuberculosis was the only bacterial agent (n = 20, 20.5%). Reports on infections in patients with HM were mostly from the South-South (n = 4), followed by South West (n = 3) and North Central (n = 2). There were no data on IFIs. The limited information on the profile of IFIs in patients with HM in Nigeria may account for the high morbidity and mortality rates associated with HM. Prospective studies should be carried out as a matter of urgency to bridge this knowledge gap.
first_indexed 2024-04-13T19:35:35Z
format Article
id doaj.art-812a88118c7148d083670bb7138f8606
institution Directory Open Access Journal
issn 2277-5706
2277-8357
language English
last_indexed 2024-04-13T19:35:35Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Clinical and Scientific Research
spelling doaj.art-812a88118c7148d083670bb7138f86062022-12-22T02:33:03ZengWolters Kluwer Medknow PublicationsJournal of Clinical and Scientific Research2277-57062277-83572022-01-0111317518010.4103/jcsr.jcsr_76_21Opportunistic infections in patients with haematological malignancies in NigeriaBassey Ewa EkengKingsley AkabaChristian IdeRita OladeleHaematological malignancies (HM) are common clinical conditions encountered in Nigeria. Patients with haematological cancers are immunocompromised and as such are at risk of invasive fungal infections (IFIs). The objective of this review was to highlight the paucity of data on IFIs in patients with HM in Nigeria and recommendations on the way forward. A literature search for publications from Nigeria on HM including case reports and reviews from 1961 to 2021 yielded 76 publications of which only 9 (11.8%) reported infections in HM. Eight publications documented infection by viruses while only one publication documented bacterial infection. Viruses (73/93, 78.5%) including human cytomegalovirus (n = 19, 20.4%), Hepatitis B virus (n = 15, 16.1%), hepatitis C virus (n = 6, 6.5%) and human T-lymphotropic virus (n = 2, 2.2%) were the commonest causative agents of infections with HIV (n = 31, 33.3%) as the predominant pathogen. Mycobacterium tuberculosis was the only bacterial agent (n = 20, 20.5%). Reports on infections in patients with HM were mostly from the South-South (n = 4), followed by South West (n = 3) and North Central (n = 2). There were no data on IFIs. The limited information on the profile of IFIs in patients with HM in Nigeria may account for the high morbidity and mortality rates associated with HM. Prospective studies should be carried out as a matter of urgency to bridge this knowledge gap.http://www.jcsr.co.in/article.asp?issn=2277-5706;year=2022;volume=11;issue=3;spage=175;epage=180;aulast=Ekengcancersfungalhaematologicalinfectionsmalignancies
spellingShingle Bassey Ewa Ekeng
Kingsley Akaba
Christian Ide
Rita Oladele
Opportunistic infections in patients with haematological malignancies in Nigeria
Journal of Clinical and Scientific Research
cancers
fungal
haematological
infections
malignancies
title Opportunistic infections in patients with haematological malignancies in Nigeria
title_full Opportunistic infections in patients with haematological malignancies in Nigeria
title_fullStr Opportunistic infections in patients with haematological malignancies in Nigeria
title_full_unstemmed Opportunistic infections in patients with haematological malignancies in Nigeria
title_short Opportunistic infections in patients with haematological malignancies in Nigeria
title_sort opportunistic infections in patients with haematological malignancies in nigeria
topic cancers
fungal
haematological
infections
malignancies
url http://www.jcsr.co.in/article.asp?issn=2277-5706;year=2022;volume=11;issue=3;spage=175;epage=180;aulast=Ekeng
work_keys_str_mv AT basseyewaekeng opportunisticinfectionsinpatientswithhaematologicalmalignanciesinnigeria
AT kingsleyakaba opportunisticinfectionsinpatientswithhaematologicalmalignanciesinnigeria
AT christianide opportunisticinfectionsinpatientswithhaematologicalmalignanciesinnigeria
AT ritaoladele opportunisticinfectionsinpatientswithhaematologicalmalignanciesinnigeria